Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden.
Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.
JAMA Otolaryngol Head Neck Surg. 2020 Jul 1;146(7):647-654. doi: 10.1001/jamaoto.2020.0869.
Adenotonsillectomy (ATE) is one of the most common surgical procedures to treat children with obstructive sleep apnea (OSA), but to our knowledge there are no randomized clinical trials confirming the benefit of surgery compared with watchful waiting in children between 2 and 4 years of age.
To determine whether ATE is more effective than watchful waiting for treating otherwise healthy children with mild to moderate OSA.
DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial was conducted from December 2014 to December 2017 at the Otorhinolaryngology Department of the Karolinska University Hospital, Stockholm, Sweden. A total of 60 children, 2 to 4 years of age, with an obstructive apnea-hypopnea index (OAHI) score of 2 or greater and less than 10, were randomized to ATE (n = 29) or watchful waiting (n = 31). A total of 53 participants (88%; ATE, n = 25; watchful waiting, n = 28) completed the study. Data were analyzed from August 2018 to December 2018.
Adenotonsillectomy.
The primary outcome was the difference between the groups in mean OAHI score change. Secondary outcomes were other polysomnography parameters, score on the Obstructive Sleep Apnea-18 (OSA-18) questionnaire, and subgroup analyses. Polysomnography and the OSA-18 questionnaire were completed at baseline and after 6 months.
Of the 60 included children, 34 (57%) were boys and the mean (SD) age at first polysomnography was 38 (9) months. Both groups had a decrease in mean OAHI score, and the difference in mean OAHI score change between the groups was small (-1.0; 95% CI, -2.4 to 0.5), in favor of ATE. However, there were large differences between the groups in favor of ATE regarding the OSA-18 questionnaire (eg, total OSA-18 score: -17; 95% CI, -24 to -10). Also, a subgroup analysis of 24 children with moderate OSA (OAHI ≥5 and <10) showed a meaningful difference in mean OAHI score change between the groups in favor of ATE (-3.1; 95% CI, -5.7 to -0.5). Of 28 children, 10 (36%) in the watchful waiting group received ATE after the follow-up, and 7 of these had moderate OSA at baseline.
This randomized clinical trial found only small differences between the groups regarding changes in OAHI, but further studies are needed. However, there were large improvements in quality of life after ATE. These results suggest that otherwise healthy children with mild OSA and mild effect on quality of life may benefit from watchful waiting, while children with moderate OSA should be considered for ATE.
ClinicalTrials.gov Identifier: NCT02315911.
腺样体扁桃体切除术(ATE)是治疗儿童阻塞性睡眠呼吸暂停(OSA)最常见的手术之一,但据我们所知,尚无随机临床试验证实手术优于 2 至 4 岁儿童的观察等待。
确定 ATE 是否比观察等待更有效地治疗轻度至中度 OSA 的健康儿童。
设计、地点和参与者:这是一项随机临床试验,于 2014 年 12 月至 2017 年 12 月在瑞典斯德哥尔摩卡罗林斯卡大学医院耳鼻喉科进行。共有 60 名年龄在 2 至 4 岁之间、阻塞性呼吸暂停低通气指数(OAHI)评分≥2 且<10 的儿童随机分为 ATE(n=29)或观察等待(n=31)组。共有 53 名参与者(88%;ATE 组 n=25;观察等待组 n=28)完成了研究。数据于 2018 年 8 月至 2018 年 12 月进行分析。
腺样体扁桃体切除术。
主要结局是两组 OAHI 评分变化的差异。次要结局是其他多导睡眠图参数、阻塞性睡眠呼吸暂停-18 问卷(OSA-18)评分以及亚组分析。多导睡眠图和 OSA-18 问卷在基线和 6 个月后完成。
60 名纳入儿童中,34 名(57%)为男孩,首次多导睡眠图的平均(SD)年龄为 38(9)个月。两组 OAHI 评分均有下降,组间 OAHI 评分变化的差异较小(-1.0;95%CI,-2.4 至 0.5),ATE 组更优。然而,ATE 组在 OSA-18 问卷方面的优势较大(例如,总 OSA-18 评分:-17;95%CI,-24 至-10)。此外,24 名中度 OSA 儿童(OAHI≥5 且<10)的亚组分析显示,ATE 组 OAHI 评分变化的组间差异有统计学意义(-3.1;95%CI,-5.7 至-0.5)。在 28 名儿童中,10 名(36%)观察等待组在随访后接受了 ATE,其中 7 名儿童基线时患有中度 OSA。
这项随机临床试验发现,两组之间 OAHI 变化的差异仅很小,但需要进一步研究。然而,ATE 后生活质量有了显著改善。这些结果表明,轻度 OSA 且对生活质量影响较小的健康儿童可能受益于观察等待,而中重度 OSA 儿童则应考虑 ATE。
ClinicalTrials.gov 标识符:NCT02315911。